X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216561
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-bets-on-respiratory-drug-licensing-deals-to-improve-business/articleshow/94232059.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216576
https://www.lawyer-monthly.com/2021/10/bayer-and-meda-sue-apotex-over-proposed-astepro-allergy-generic/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-astepro-allergy-otc-21382-azelastine-hydrochloride-2055mcg20ml-nasal-spray-1633682847.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-childrens-astepro-allergy-otc-21382-azelastine-hydrochloride-2055mcg20ml-nasal-spray-1633682925.pdf
https://www.fiercepharma.com/pharma/no-more-prescriptions-bayer-turns-allergies-drug-over-counter-fda-nod-for-astepro
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212775
https://www.biospace.com/article/releases/cebina-reports-positive-findings-on-the-potency-of-azelastine-a-widely-used-anti-histamine-as-anti-covid-19-approach/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212289
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210092
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210032
https://www.globenewswire.com/news-release/2019/08/26/1906706/0/en/Akorn-Receives-FDA-Approval-for-Azelastine-Hydrochloride-Nasal-Spray-0-15.html
https://www.pharmacompass.com/pdf/news/akorn-inc-receives-fda-warning-letter-1562734261.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207610
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-13-2019-1550065023.pdf
https://www.raps.org/news-and-articles/news-articles/2018/11/fda-hands-akorn-483-over-gmp-issues-at-new-jersey?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%205%20November
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm624887.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-15-2018-1534336681.pdf
https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax
https://www.ftc.gov/news-events/press-releases/2018/07/ftc-approves-final-order-imposing-conditions-merger-generic-drug
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2018-1519194777.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208199
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207243
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208156
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091409
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-for-blood-pressure-drug/articleshow/60083383.cms
http://www.in-pharmatechnologist.com/Processing/Mylan-confirms-plan-to-close-Meda-Soma-plant-in-Illinois
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202609
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207243
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM440188.pdf
Market Place
Share 
